BR100 Increased By (0.67%)
BR30 Increased By (0.7%)
KSE100 Increased By (0.71%)
KSE30 Increased By (0.76%)
AGHA 6.40 Increased By ▲ 0.02 (0.31%)
BECO 4.36 Increased By ▲ 0.01 (0.23%)
BML 62.49 Decreased By ▼ -0.06 (-0.1%)
BOP 31.37 Decreased By ▼ -0.02 (-0.06%)
CNERGY 11.82 Increased By ▲ 0.09 (0.77%)
CSIL 5.77 Decreased By ▼ -0.14 (-2.37%)
FCCL 61.70 Decreased By ▼ -0.01 (-0.02%)
FFL 14.92 Increased By ▲ 0.13 (0.88%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.32 No Change ▼ 0.00 (0%)
KOSM 5.84 Decreased By ▼ -0.06 (-1.02%)
LOTCHEM 24.87 Increased By ▲ 0.18 (0.73%)
MLCF 105.40 Increased By ▲ 1.47 (1.41%)
NBP 174.20 Increased By ▲ 0.88 (0.51%)
NCPL 51.94 Increased By ▲ 0.11 (0.21%)
NPL 54.40 Increased By ▲ 0.37 (0.68%)
OGDC 318.50 Increased By ▲ 2.63 (0.83%)
PACE 9.29 Increased By ▲ 0.03 (0.32%)
PAEL 35.66 Increased By ▲ 0.08 (0.22%)
PIBTL 14.14 Increased By ▲ 0.48 (3.51%)
PPL 228.35 Increased By ▲ 2.28 (1.01%)
PRL 81.70 Increased By ▲ 1.42 (1.77%)
PTC 46.96 Increased By ▲ 0.32 (0.69%)
SSGC 23.97 Increased By ▲ 0.15 (0.63%)
TBL 9.24 No Change ▼ 0.00 (0%)
TELE 7.68 Increased By ▲ 0.13 (1.72%)
TPL 24.95 Increased By ▲ 0.41 (1.67%)
TPLP 12.92 Decreased By ▼ -0.07 (-0.54%)
TREET 26.00 Increased By ▲ 0.02 (0.08%)
TRG 53.60 Increased By ▲ 0.27 (0.51%)
World

Malaysia buys AstraZeneca COVID-19 vaccines, seeks more from China, Russia

  • The government expects to receive the first batch of the Pfizer-BioNTech vaccine in February, he added. Malaysia was the first country in Southeast Asia to strike a deal with the US drugmaker.
Published Updated
By

KUALA LUMPUR: Malaysia has signed a deal to procure 6.4 million doses of AstraZeneca's coronavirus vaccine, and is in final talks with Chinese and Russian manufacturers to secure more, Prime Minister Muhyiddin Yassin said on Tuesday.

The Southeast Asian country has already secured 12.8 million doses from its deal with Pfizer-BioNTech signed last month, as well as from its participation in the global COVAX facility, backed by the World Health Organization (WHO).

"This means that we have secured vaccine supplies to cover 40% (of the population)," Muhyiddin said in a televised address.

Malaysia expects to buy enough supplies to inoculate 26.5 million people, or more than 80% of its people.

The procurement deals are expected to cost $504.4 million (2.04 billion ringgit) in total, he said.

In order to boost confidence in the safety and efficacy of the vaccines, Muhyiddin said he would be among the first to receive a dose, followed by frontliners and high-risk groups such as senior citizens.

The government expects to receive the first batch of the Pfizer-BioNTech vaccine in February, he added. Malaysia was the first country in Southeast Asia to strike a deal with the US drugmaker.

Under the Pfizer deal, it will receive 1 million doses in the first quarter of 2021 and 1.7 million, 5.8 million and 4.3 million doses in the subsequent quarters.

Neighbouring Singapore was the first Asian nation to take delivery of the Pfizer vaccine on Monday when its first batch arrived from Belgium.

Comments

Comments are closed for this article.